Epidermal growth factor receptor (EGFR) has been particularly well studied in head and neck cancer (HNC) because of its association with the cellular mechanisms involved in tumour progression. High ...
AFM24, in combination with adoptive NK cells, leads to dose-dependent tumor regression Heidelberg, Germany, April 12, 2021 – Affimed N.V. (Nasdaq: AFMD), a clinical-stage immuno-oncology company ...
The clinical success of small-molecule vascular disrupting agents (VDAs) depends on their combination with conventional therapies. Scheduling and sequencing remain key issues in the design of ...
Pharmacokinetic differences and ethnic variability in tolerance of cytotoxic drugs. Comprehensive protein profiling with iTRAQ-based LC-MS/MS to identify proteins associated with doxorubicin and ...
Since it is very difficult to achieve the ideal situation with monotherapy, attempts have been made to create a more ideal treatment for hypertension by combining complementary drugs in low doses. The ...
Current student Rohan Rajiv is blogging once a week about important lessons he is learning at Kellogg. Read more of his posts here. In my last MBA learning post, we dove into the idea of managing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results